Cannabis Science Subsidiary Michigan Green Technologies (MGT) Announces Key Progress With its Michigan State Initiatives & A New Advisory Board with Significant Board Members

News provided by

Mar 13, 2015, 01:59 ET

COLORADO SPRINGS, Colo., March 13, 2015 /PRNewswire/ -- Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development related consulting, is please to announce key progress with its subsidiary, Michigan Green Technologies.

"MGT has continued to work with key legislators in Michigan to rectify the Michigan Medical Marihuana Act of 2008. Michigan's medical cannabis program has not seen the success in other states and if proper legislation can be implemented then a proper cannabis economy with integrity can begin to function, we believe we are playing a key role in this outstanding progress. The participants will flourish under proper legal protection that law enforcement can embrace, and the State of Michigan and its citizens will benefit substantially," stated John Dalaly, CEO of Michigan Green Technologies.

Since 1987 John D Dalaly has provided hospital management services to over 47 hospitals in ten country's that included, staffing, education, lecturing recruiting and operations and design of healthcare applications. John has also with Southern Mississippi university and MSU developed a state of the art hospital management systems for third world countries and well as the ministry of health in Saudi, Kuwait, Iraq, Dubai, Amman, Muscat Oman, Mexico and Africa. John also developed from 1987 till present the mobile medical unit's program clinic on wheels that has provided outreach programs nationally and internationally. John's healthcare knowledge domestically and internationally will be used to advance the current Michigan State initiatives enhancing economic and opportunities within the state of Michigan. John's political ties nationally and internationally give him the ability to get the job done.

Working with Michigan State legislation is the priority; MGT has actively signed several key members from Michigan to the new Advisory Board such as former law enforcement officers, former legislators, medical professionals, and other strategic personnel to help with the anticipated workload. The goal of the advisory board is to offer a diverse range of additional resources to assist the executive team in implementing operations in the State of Michigan.

To learn more about Michigan Green Technologies, please see the Company's website at the following link: www.michigangreentechnologies.com

To learn more about Cannabis Science, please see the Company's website and recent announcements at the following link: www.cannabisscience.com.

About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers and neurological conditions.

Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements

Media Contacts:

VAN STONE PUBLICITY
Carrol Van Stone
[email protected]
Tel: 304-671-0244

Cannabis Science, Inc.
Raymond C. Dabney
President & CEO, Co-Founder
[email protected]
Tel: 1.888.889.0888

Robert Kane
Director & CFO
[email protected]
Tel: 1.888.889.0888

www.cannabisscience.com

www.michigangreentechnologies.com

SOURCE Cannabis Science, Inc.